The Banook Group, global provider of cardiac safety, central imaging and endpoint adjudication services for clinical trials, has opened a new subsidiary at the Neomed Institute, a centre of excellence in clinical research, in Montreal, Canada.
Pascal Voiriot, Chair of the Banook Group, said: “Our new location will enable us to closely observe technology improvements, forge new partnerships and provide more opportunities to attend key industry events.”
Philippe Walker, General Manager R&D and CSO. “The arrival of the Banook Group inside the Neomed Institute is a win-win situation; Neomed gets a robust service provider in clinical trials and the Banook Group has access to our incredible know-how on the North America biotechnology market.”